Nicholas Mitsiades
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments 40
- Oncology top 0.5%
- Cancer-related Molecular Pathways 19
- Cancer Research top 0.5%
- Molecular Biology top 0.2%
- Cell death mechanisms and regulation 36
- Ubiquitin and proteasome pathways 31
- PI3K/AKT/mTOR signaling in cancer 12
- Protein Degradation and Inhibitors 11
- Ophthalmology top 0.5%
-
- Prostate Cancer Treatment and Research 25
-
- interferon and immune responses 11
- Co-authors
- Constantine S. MitsiadesKenneth C. AndersonTeru HideshimaVassiliki PoulakiNikhil C. MunshiPaul G. RichardsonDharminder ChauhanSteven P. Treon
- Cited by
- HematologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of Sciences (5 papers)Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesGreeceGermany
In The Last Decade
Nicholas Mitsiades
169 papers receiving 14.9k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Hematology 4.6k
- Oncology 4.5k
- Cancer Research 2.4k
- Molecular Biology 10.1k
- Ophthalmology 924
Countries citing papers authored by Nicholas Mitsiades
This map shows the geographic impact of Nicholas Mitsiades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Mitsiades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Mitsiades more than expected).
Fields of papers citing papers by Nicholas Mitsiades
This network shows the impact of papers produced by Nicholas Mitsiades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Mitsiades. The network helps show where Nicholas Mitsiades may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicholas Mitsiades, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 48 | |
| 7 | 2020 | 12 | |
| 8 | 2018 | 21 | |
| 9 | 2014 | 132 | |
| 10 | 2012 | 175 | |
| 11 | 2009 | 53 | |
| 12 | 2009 | 105 | |
| 13 | 2009 | 38 | |
| 14 | 2007 | 152 | |
| 15 | 2004 | 116 | |
| 16 | IGF-II is a major proliferative/anti-apoptotic cytokine and a therapeutic target in multiple myeloma, other hematologic neoplasias and solid tumors. | 2004 | 1 |
| 17 | Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3-kinase/AKT signaling beta. | 2003 | 33 |
| 18 | 2002 | 320 | |
| 19 | 2002 | 38 | |
| 20 | 1998 | 90 |
About Nicholas Mitsiades
Nicholas Mitsiades is a scholar working on Hematology, Cancer Research and Oncology, having authored 172 papers that have together received 15.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (40 papers), Cell death mechanisms and regulation (36 papers), Ubiquitin and proteasome pathways (31 papers), Prostate Cancer Treatment and Research (25 papers), Cancer-related Molecular Pathways (19 papers), PI3K/AKT/mTOR signaling in cancer (12 papers), interferon and immune responses (11 papers) and Protein Degradation and Inhibitors (11 papers). The work is most often cited by research in Hematology (4.6k citations), Oncology (4.5k citations) and Cancer Research (2.4k citations). Nicholas Mitsiades has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Constantine S. Mitsiades, Kenneth C. Anderson, Teru Hideshima, Vassiliki Poulaki, Nikhil C. Munshi, Paul G. Richardson, Dharminder Chauhan, Steven P. Treon, Robert Schlossman and Maria Tsokos. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.